Display options
Cite
Hu J, Chen R, An J, et al. Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway. Front Pharmacol. 2021;12:758962doi: 10.3389/fphar.2021.758962.
Hu, J., Chen, R., An, J., Wang, Y., Liang, M., & Huang, K. (2021). Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway. Frontiers in pharmacology, 12758962. https://doi.org/10.3389/fphar.2021.758962
Hu, Ji, et al. "Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway." Frontiers in pharmacology vol. 12 (2021): 758962. doi: https://doi.org/10.3389/fphar.2021.758962
Hu J, Chen R, An J, Wang Y, Liang M, Huang K. Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway. Front Pharmacol. 2021 Dec 01;12:758962. doi: 10.3389/fphar.2021.758962. eCollection 2021. PMID: 34925018; PMCID: PMC8672219.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2021 Dec 01;12:758962. doi: 10.3389/fphar.2021.758962. eCollection 2021.

Dauricine Attenuates Vascular Endothelial Inflammation Through Inhibiting NF-κB Pathway.

Frontiers in pharmacology

Ji Hu, Ru Chen, Jie An, Yilong Wang, Minglu Liang, Kai Huang

Affiliations

  1. Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  2. Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  3. Department of Cardiology, Handan First Hospital, Handan, China.
  4. Department of Cardiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

PMID: 34925018 PMCID: PMC8672219 DOI: 10.3389/fphar.2021.758962

Abstract

Endothelial cells are the fundamental components of blood vessels that regulate several physiological processes including immune responses, angiogenesis, and vascular tone. Endothelial dysfunction contributes to the development of various diseases such as acute lung injury, and endothelial inflammation is a vital part of endothelial dysfunction. Dauricine is an extract isolated from

Copyright © 2021 Hu, Chen, An, Wang, Liang and Huang.

Keywords: NF-κB pathway; acute lung injury; dauricine; endothelial dysfunction; inflammation

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. J Cell Mol Med. 2020 Nov;24(21):12258-12271 - PubMed
  2. Antioxidants (Basel). 2020 Jul 06;9(7): - PubMed
  3. Shock. 2002 May;17(5):433-8 - PubMed
  4. Toxins (Basel). 2020 Jun 01;12(6): - PubMed
  5. Arch Biochem Biophys. 2020 Dec 15;696:108595 - PubMed
  6. Altern Med Rev. 2006 Jun;11(2):128-50 - PubMed
  7. Arch Biochem Biophys. 2019 May 15;666:99-106 - PubMed
  8. Nat Commun. 2017 Dec 11;8(1):2049 - PubMed
  9. Curr Vasc Pharmacol. 2013 Mar 1;11(2):161-9 - PubMed
  10. J Mol Med (Berl). 2009 Dec;87(12):1251-61 - PubMed
  11. J Thorac Cardiovasc Surg. 2021 May;161(5):e377-e393 - PubMed
  12. J Cell Physiol. 2010 Oct;225(1):266-75 - PubMed
  13. Mediators Inflamm. 2016;2016:6813016 - PubMed
  14. Biochem Biophys Res Commun. 1997 Jan 3;230(1):44-8 - PubMed
  15. Circulation. 2014 Jan 7;129(1):66-76 - PubMed
  16. Zhongguo Yao Li Xue Bao. 1986 Sep;7(5):419-22 - PubMed
  17. Circulation. 1992 May;85(5):1927-38 - PubMed
  18. J Pharmacol Sci. 2018 May;137(1):12-19 - PubMed
  19. Am J Respir Crit Care Med. 2020 Aug 1;202(3):361-370 - PubMed
  20. Am J Med Sci. 2015 Jan;349(1):2 - PubMed
  21. Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):e26-31 - PubMed
  22. J Immunol. 1997 Oct 1;159(7):3508-18 - PubMed
  23. J Ethnopharmacol. 2020 Jan 10;246:112246 - PubMed
  24. J Pharm Pharm Sci. 2016;19(1):114-26 - PubMed
  25. Nat Rev Nephrol. 2019 Feb;15(2):87-108 - PubMed
  26. Cardiovasc Res. 2010 May 1;86(2):211-8 - PubMed
  27. Am J Chin Med. 2007;35(3):477-86 - PubMed
  28. Semin Immunopathol. 2018 Feb;40(2):215-224 - PubMed
  29. J Immunol Res. 2017;2017:7424307 - PubMed
  30. Mol Med Rep. 2018 May;17(5):7403-7408 - PubMed
  31. Eur J Pharmacol. 2019 Dec 1;864:172710 - PubMed
  32. Circ Res. 2016 Feb 19;118(4):620-36 - PubMed
  33. J Cardiovasc Pharmacol Ther. 2019 May;24(3):278-287 - PubMed
  34. Adv Exp Med Biol. 2017;956:511-540 - PubMed
  35. Adv Exp Med Biol. 2017;1003:71-91 - PubMed

Publication Types